ImmunoScape
Business Services · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Scotts Road #24-10, Singapore, Central...Website
www.immunoscape.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ImmunoScape
ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely high resolution. The company's Deep Immunomics platform combines mass cytometry, single cell sequencing, and proprietary computational bioinformatics, data analysis, and visualization tools to provide novel, reproducible immune profiling information.Explore more
ImmunoScape Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ImmunoScape your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ImmunoScape had a recent Job posting/layoffs
Check if ImmunoScape has recently received funding, and reach out quickly before it becomes old news!
ImmunoScape, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ImmunoScape has new funding data
Congratulate Masked Content for being promoted to Masked Content at ImmunoScape
Check out if ImmunoScape is spiking on competitors!
Earning: See what the market has to say on ImmunoScape recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ImmunoScape launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined ImmunoScape as Masked Content
Find 2 more new buyers
Compare Similar Companies to ImmunoScape
Compare insights from companies similar to ImmunoScape, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$114.2M
51-200
Public
$462.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Company Profile Activity
Activity Insights
ImmunoScape is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ImmunoScape is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ImmunoScape.
ImmunoScape financials insights
Gather financial insights about ImmunoScape, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$11M
2021
Unspecified
$14M
2022
Other Financing Round
$14M
ImmunoScape Tech Stack
A closer look at the technologies used by ImmunoScape
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Award
Award, Research & Development, Search
Funding
ImmunoScape News & Media
ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape
ST. PAUL, Minn., Sept. 18, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that ImmunoScape Pte. Ltd. (a Singapore-U.S. based TCR-T therapy company) has been awarded a G-Rex® Grant....ImmunoScape Announces Three Presentations Highlighting TCR Pipeline and Discovery Platform at the American Association for Cancer Research (AACR) Annual Meeting 2024
SAN DIEGO & SINGAPORE--(BUSINESS WIRE)--ImmunoScape announced that three abstracts have been accepted for poster presentations at the 2024 AACR Annual Meeting in San Diego, California.ImmunoScape Leadership to Present at Upcoming Industry Conferences
SAN DIEGO & SINGAPORE--(BUSINESS WIRE)--ImmunoScape senior executives are presenting at several upcoming industry events.ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics
SAN DIEGO & SINGAPORE--(BUSINESS WIRE)--The collaboration aims to produce off-the-shelf TCR-based bispecific molecules that could lead to more effective treatments for solid tumors.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ImmunoScape
Sign Up For FreeTo access detailed company insights
ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely high resolution. The company's Deep Immunomics platform combines mass cytometry, single cell sequencing, and proprietary computational bioinformatics, data analysis, and visualizatio... Read More
